id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0574-0005,FDA,FDA-2009-D-0574,Guidance for Industry Q4B Evalution and Recommemdation of Pharmacopoeial Texts for Use in the ICH Regions,Other,GDL-Guidance (Supporting and Related Materials),2010-09-02T04:00:00Z,2010,9,2010-09-02T04:00:00Z,,2019-10-23T14:16:17Z,,0,0,0900006480b433e1
FDA-2009-D-0574-0004,FDA,FDA-2009-D-0574,"International Conference on Harmonisation: Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts, etc.;Availability",Notice,NAD-Notice of Availability of Data,2010-09-02T04:00:00Z,2010,9,2010-09-02T04:00:00Z,,2019-10-23T14:16:02Z,2010-21979,0,0,0900006480b43025
FDA-2009-D-0574-0002,FDA,FDA-2009-D-0574,Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,2010-02-17T04:59:59Z,2009-12-17T20:39:09Z,,0,0,0900006480a6d53a
FDA-2009-D-0574-0001,FDA,FDA-2009-D-0574,International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions,Notice,NAD-Notice of Availability of Data,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,2010-02-17T04:59:59Z,2009-12-17T20:33:56Z,E9-29988,0,0,0900006480a6ca37